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http://dx.doi.org/10.1016/j.kjms.201
1607-551X/Copyright ª 2015, KaohsiuAbstract The aims of the study were to identify the differentially expressed genes (DEGs) be-
tween primary melanomas and metastasis melanomas (MMs), and to investigate the mecha-
nisms of MMs. The microarray data GSE8401 including 31 primary melanomas and 52 MMs
were downloaded from Gene Expression Omnibus. DEGs were identified using the Linear
Models for Microarray Data package. The functional and pathway enrichment analyses were
performed for DEGs. Identification of transcription factors, tumor-associated genes (TAGs),
and tumor suppressor genes (TSGs) were performed with the TRANSFAC, TAG, and TSGene da-
tabases, respectively. A proteineprotein interaction network was constructed using Search
Tool for the Retrieval of Interacting Genes. The modules construction and analysis was per-
formed using Molecular Complex Detection and Gene Cluster with Literature Profiles, respec-
tively. In total, 1004 upregulated and 1008 downregulated DEGs were identified. The
upregulated DEGs, such as CDK1, BRCA1, MAD2L1, and PCNA, were significantly enriched in cell
cycles, DNA replication, and mismatch repair. The downregulated DEGs, such as COLIAL,
COL4A5, COL18A1, and LAMC2, were enriched in cell adhesion and extracellular matrix-
receptor interaction. BRCA1 was identified as a transcription factor and TSG, and COL18A1
and LAMC2 were identified as a TSG and TAG, respectively. The upregulated DEGs had higher
degrees in the proteineprotein interaction network and module, such as PCNA, CDK1, and
MAD2L1, and the heat map showed they were clustered in the functions of cell cycle and di-
vision. These results may demonstrate the potential roles of DEGs such as CDK1, BRCA1,
COL18A1, and LAMC2 in the mechanism of MM.
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Melanoma is a lethal skin cancer that accounts for 4e5% of
all cancers and metastatic melanoma (MM) accounts for 80%
of skin cancer deaths [1e3]. Metastasis is the dispersal of
cancer cells from their primary loci to distant organs and
accounts for > 90% of deaths in cancer patients [4]. About
80% of melanomas are diagnosed at localized stages,
whereas one-third of those patients will develop MMs [5]. As
shown by both clinical and animal model studies, metas-
tasis is a severe event [4]. Therefore, it is very important to
understand the mechanisms of MM.
Regarding the causes of melanoma, there is a complex
interaction of environmental (exogenous) and endogenous
risk factors in developing malignant melanomas or MM [4].
UV radiation is clearly the predominant environmental risk
factor of melanoma and accounts forw86% of MMs. BRAF, a
component of the Ras-mitogen-activated protein kinase-
ERK pathway, is commonly targeted in cancers with an
overall occurrence of 7%, whereas the BRAF mutations
frequency approaches 70% in MM [6e9]. BRAF activation has
been shown to lead to the development of benign nevi,
while the cooperation of the deficiency of the p53 pathway
is required for the progression to frank melanoma. In
addition, constitutive expression of AKT has been observed
in nearly 60% of melanomas and inhibition of AKT in the
onset and further development of melanoma altered the
progression of melanoma invasion and metastasis.
Recently, high-dose interferon-a therapy and interleukin-2
therapy, antibody blockade of cytotoxic T-lymphocyte-
associated protein 4, inhibitors of the mitogen-activated
protein kinase pathway, and adoptive cell therapy have
also been used in the treatment of melanoma. In spite of
this, the prognosis for patients with high-risk or advanced
MM remains poor compared with the increasing incidence of
melanoma.
Several studies have shown that primary tumors and
their metastases have different gene expression signatures
that predicts their propensity to metastasize. As reported
by Xu et al [4], 150 differentially expressed genes (DEGs)
showed different expression profiles between the primary
melanomas (PMs) and MMs identified through gene expres-
sion microarray data, and functional and pathway enrich-
ment analysis showed the DEGs were involved in processes
such as extracellular matrix (ECM)-receptor interaction,
focal adhesion, as well as the transforming growth factor
(TGF)-beta signaling pathway, suggesting the important
roles of DEGs in the metastasis of melanoma. However,
further identification of the transcription factors (TFs),
tumor-associated genes (TAGs), and tumor suppressor
genes (TSGs), as well as the construction and analysis of the
proteineprotein interaction (PPI) network and the subnet-
work of the DEGs were not performed.
In order to further investigate the mechanisms of MM,
the microarray data GSE8401 from Xu et al [4] were
downloaded. Identification of DEGs were performed with
lower cut-off criteria for amplifying the inclusion genes. In
addition to the functional and pathway enrichment anal-
ysis, construction and analysis of the PPI network and
module network of the DEGs were performed for better
understanding the biological processes of MM. The rean-
alysis of the microarray data would provide more abundantinformation for understanding the mechanisms of MM, as
well as for the strategey of diagnosis and therapeutic
treatment.Methods
Microarray data and data preprocessing
The gene expression microarray data of melanoma were
obtained from the national center for biotechnology in-
formation (NCBI) Gene Expression Omnibus (http://www.
ncbi.nlm.nih.gov/geo) and were accessible through Gene
Expression Omnibus series accession number GSE8401 [4].
The platform of this data was GPL96 [HG-U133A] Affymetrix
Human Genome U133A Array. A total of 83 samples,
including 31 PM samples and 52 aggressive MM samples were
available in the microarray data. The probe files were
downloaded for further analysis.
Probe sets were mapped to NCBI Entrez genes using
Gene ID converter. If there were multiple probe sets that
corresponded to the same gene, the average value was
calculated for further analysis. The probe was filtered if it
had multiple genes. The data were normally distributed
through log 2 transformation, and were normalized using
preprocess Core package [10].
Identification of DEGs
For the GSE8401 dataset, the classical t test in Linear
Models for Microarray Data package of R was used to
identify the DEGs [11]. Benjamini and Hochberg’s [12]
method was used to adjust the raw p value into false dis-
covery rate. The cut-off criteria for DEGs were jlog2fold
changej > 0.58 and false discovery rate < 0.05.
Functional and pathway enrichment analysis
GO (Gene Ontology) analysis is a functional study method of
large-scale transcriptomic data or genomic, while KEGG
(Kyoto Encyclopedia of Genes and Genomes) pathway
database provides information on how molecules or genes
work [13]. In order to investigate the biofunction of DEGs in
tumor progression, GO functional enrichment analysis in
biological process (BP), molecular function (MF), cellular
component (CC) categories were performed using the GO
database, while the pathway enrichment analysis was
performed using the KEGG database. The threshold was set
as p < 0.01.
Identification of TFs, TSGs, and TAGs
TRANSFAC database (http://www.embl-heidelberg.de/srs/
srsc) is not only a database about eukaryotic transcription
regulating DNA sequence elements, but also a database
about the TFs binding to DNA sequences and acting through
them. To determine whether the DEGs had a transcription
regulation function, TF prediction of upregulated and
downregulated DEGs were performed using the TRANSFAC
database, respectively.
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collects specific information of target genes from various
resources and is a semiautomatic information retrieving
engine [14]. Additionally, TSGene database (http://bioinfo.
mc.vanderbilt.edu/TSGene/) provides a comprehensive
resource of TSGs for the cancer research community to
further experimental designs [15]. Furthermore, a
comprehensive TSG catalog for advanced systems biology-
based analyses can be provided by the TSGene database
[15]. To identify genes that play important roles in carci-
nogenesis and facilitate cancer research, TSGs and TAGs in
upregulated and downregulated DEGs were identified using
the TSGene database and TAG database, respectively.
Construction of PPI network and the module
analysis
The STRING (Search Tool for the Retrieval of Interacting
Genes) database provides uniquely comprehensive
coverage and ease of access to both experimental as well as
predicted interaction information [16]. To better under-
stand DEGs from an interactive respective, we used the
STRING database to build an interaction network of
encoding products of all of the DEGs, i.e., the PPI network.
A STRING score of 0.4 was set as the reliability threshold.
Cytoscape is a standard tool for integrated analysis and
visualization of biological networks. Cytoscape software
(version 2.8, http://www.cytoscape.org/) was used to
visualize the PPI network. Then, using the scale-free
properties of PPI networks, connectivity degree analysis
was performed and hub nodes were obtained.
Molecular Complex Detection (MCODE) in Cytoscape, a
novel graph theoretic clustering algorithm that detects
densely connected regions in large PPI networks that may
represent molecular complexes, was used to obtain mod-
ules of the PPI network with the parameters set to the
default values. Gene Cluster with Literature Profiles ana-
lyzes human genes with enriched keywords and molecular
interactions to construct molecular networks and modulesTable 1 The top five enriched Gene Ontology functions for the
Category ID Name Count
BP GO:0000278 Mitotic cell cycle 139
GO:0000280 Nuclear division 67
GO:0007049 Cell cycle 189
GO:0007067 Mitosis 67
GO:0022402 Cell cycle process 157
CC GO:0031974 Membrane-enclosed lumen 245
GO:0031981 Nuclear lumen 192
GO:0043227 Membrane-bounded organelle 628
GO:0043231 Intracellular membrane-bounded
organelle
626
GO:0043233 Organelle lumen 242
MF GO:0008094 DNA-dependent ATPase activity 15
GO:0036094 Small molecule binding 179
GO:0005515 Protein binding 466
GO:0005524 ATP binding 117
GO:0000166 Nucleotide binding 169
BP Z biological process; CC Z cellular components; MF Z molecularrelated to the free terms [17]. Finally, the analysis and
construction of the heat map of the module was performed
with Gene Cluster with Literature Profiles.
Results
Identification of DEGs
After mapping to the NCBI Entrez genes and normalization,
the expression spectrum matrix including 12,750 genes was
obtained. Afterwards, a total of 2012 DEGs were identified,
including 1004 upregulated DEGs (such as CDK1, MAD2L1,
RFC4, PCNA, BRCA1, SPC25, SMC2, and SMC4) and 1008
downregulated DEGs (such as COL1A1, COL6A1, COL18A1,
LAMA2, LAMC2, SEMA3G, SEMA3C, S100A2, and S100A7).
Functional and pathway enrichment analysis
Through the functional enrichment analysis in the BP
category, upregulated DEGs were significantly involved in
mitotic cell cycle (p < 0.01), such as CDK1, MAD2L1, RFC4,
and PCNA; nuclear division (p < 0.01), such as CDK1,
MAD2L1, and SMC2 (Table 1). After enrichment analysis in
the CC category, the upregulated DEGs were significantly
involved in membrane-enclosed lumen (p < 0.01), such as
CDK1, RFC4, PCNA, and SMC2; membrane-bounded organ-
elle (p < 0.01), such as CDK1, MAD2L1, RFC4, and PCNA
(Table 1). For the analysis in the MF category, the upregu-
lated DEGs were significantly involved in DNA-dependent
ATPase activity (p Z 3.49E-06), such as RFC3, MCM6,
MCM7, and MSH6; small molecule binding (p Z 4.29E-06),
such as CDK1, RFC4, SMC2, and SMC4; protein binding
(p Z 5.43E-06), such as CDK1, MAD2L1, RFC4, and SMC2
(Table 1). Moreover, after the annotation of KEGG pathway,
the upregulated DEGs were significantly involved in cell
cycle (p Z 5.19E-11), such as CDK1, MAD2L1, RFC4, and
PCNA; DNA replication (pZ 9.22E-07), such as RFC3, RFC4,
and PCNA; mismatch repair (p Z 4.53E-05), such as RFC3,upregulated differentially expressed genes.
Gene symbol p
CDK1, MAD2L1, RFC4, SMC2, SMC4, PCNA, BRCA1 < 0.01
CDK1, MAD2L1, MAD2L1BP, SMC2, SMC4, SPC25 < 0.01
MAD2L1, CDK1, SMC2, HMGA2, SPC25, SMC4 < 0.01
CDK1, MAD2L1, SMC2, SMC4, HMGA2, SPC25 < 0.01
CDK1, MAD2L1, SMC2, SMC4, HMGA2, SPC25 < 0.01
CDK1, RFC4, PCNA, SMC2, COL11A1, HMGA2 < 0.01
CDK1, HMGA2, SMC2, PCNA, BRCA1, RFC4 < 0.01
CDK1, MAD2L1, RFC4, PCNA, COL11A1, SMC4 < 0.01
CDK1, COL11A1, SMC4, HMGA2, SPC25, SMC2 < 0.01
BRCA1 CDK1, COL11A1, HMGA2, SMC2, RFC4 < 0.01
RFC3, MCM6, MCM7, MSH6, MSH2, DNA2 3.49E-06
CDK1, RFC4, RFC3, SMC2, SMC4, MCM7 4.29E-06
CDK1, MAD2L1, RFC4, SMC2, MAGEA3, MAGEA6 5.43E-06
CDK1, SMC4, SMC2, MCM6, RFC4, MCM7 6.26E-06
CDK1, SMC4, SMC2, RFC3, MCM6, MCM7 6.84E-06
functions.
Table 2 The Kyoto Encyclopedia of Genes and Genomes pathways enrichment analysis of the upregulated differentially
expressed genes.
ID Name Count Gene symbol p
4110 Cell cycle 30 CDK1, MAD2L1, RFC4, PCNA, SMC2, BRCA1 5.19E-11
3030 DNA replication 12 RFC2, RFC3, RFC4, PCNA, MCM6, MCM7 9.22E-07
4141 Protein processing in endoplasmic reticulum 26 SEC23A, SEC24A, SEC24B, SEC24D, SEC23B, EIF2AK3 8.81E-06
3430 Mismatch repair 8 RFC2, RFC3, RFC4, PCNA, MSH2, MSH6 4.53E-05
4114 Oocyte meiosis 16 MAD2L1, CDK1, CCNE1, CCNE2, CCNB1, CCNB2 0.001
4115 p53 signaling pathway 11 CDK1, CCNE1, CCNE2, CCNB1, CCNB2, CHEK1 0.003
240 Pyrimidine metabolism 13 POLA2, POLE2, POLR3D, POLR2K, PRIM1, PRIM2 0.008
520 Amino sugar & nucleotide sugar metabolism 8 UAP1, GFPT1, FPGT, PGM3, AMDHD2, GALK1 0.009
4120 Ubiquitin mediated proteolysis 16 BRCA1, CDC20, UBE2C, UBE2W, UBE2D, UBE2S 0.009
556 T. Qiu et al.RFC4, and PCNA; and p53 signaling pathway (p Z 0.003),
such as CDK1, CCNE2, and CCNB1 (Table 2).
Additionally, after enrichment analysis in BP category,
the downregulated DEGs were significantly involved in cell
adhesion (p < 0.01), such as COL1A1, COL8A2, and LAMC2;
and cell proliferation (p < 0.01), such as COL8A2, COL18A1,
and FOXC1 (Table 3). Through the CC category analysis, the
downregulated DEGs were significantly involved in extra-
cellular region (p < 0.01), such as COL1A1, COL8A2, and
S100A12; extracellular space (p < 0.01), such as COL1A1,
COL6A2, and COL18A1 (Table 3). For MF category, the
downregulated DEGs were significantly involved in struc-
tural molecule activity (p Z 2.46E-12), such as COL1A1,
COL8A2, and LAMA2; and calcium ion binding (p Z 4.29E-
10), such as S100A12, S100A7, and S100A8 (Table 3). Be-
sides, through the pathway enrichment analysis, the
downregulated DEGs were significantly involved in axon
guidance (p Z 2.98E-07), such as SEMA3G, SEMA3C, and
SEMA3F; ECM-receptor interaction (p Z 1.59E-05), such as
COL1A1, COL6A1, and LAMC2; pathways in cancer
(p Z 2.60E-05), such as LAMA2, LAMA3, and LAMC3; andTable 3 The top five enriched Gene Ontology functions for the
Category ID Name Count
BP GO:0007155 Cell adhesion 140 COL1
GO:0007275 multicellular Organismal
development
375 SEMA
GO:0008283 Cell proliferation 183 COL8
GO:0008544 Epidermis development 83 LAMC
GO:0009888 Tissue development 209 COL1
CC GO:0005576 Extracellular region 249 COL1
GO:0005615 Extracellular space 122 COL1
GO:0031012 Extracellular matrix 70 COL1
GO:0044421 Extracellular region part 160 COL1
GO:0044459 Plasma membrane part 181 COL1
MF GO:0005198 Structural molecule activity 81 COL1
GO:0005509 Calcium ion binding 79 S100A
GO:0004252 serine-type Endopeptidase
activity
30 KLK1
GO:0005200 Structural constituent of
cytoskeleton
23 TUBB
GO:0008236 Serine-type peptidase activity 32 KLK1
BP Z biological process; CC Z cellular components; MF Z moleculafocal adhesion (pZ 8.96E-05), such as COL1A1, LAMA2, and
LAMC3 (Table 4).
Identification of TFs, TAGs, and TSGs
For the upregulated DEGs, 34 TFs (such as BRCA1, HIF1A,
TAF4, and HMGA2), 18 TAGs (such as HMGA2, CCNA2,
PIK3CA, and MYBL1), and 42 TSGs (such as BRCA1, SMAD4,
MSH2, and CDC73) were identified. Meanwhile, 55 TFs (such
as TP63, KLF4, KLF13, and FOXC1), 30 TAGs (such as CD24,
LAMC2, CCND1, and FGFR2), and 67 TSGs (such as TP63,
CDKN1C, KLF5, and COL18A1) were identified among the
downregulated DEGs (Table 5).
PPI network and module analysis
In total, 1574 nodes and 13,876 edges were included in the
PPI network (Figure 1). The top five DEGs with the highest
degrees were PCNA (degree Z 188), CDK1 (degree Z 180),
MAD2L1 (degree Z 171), RFC4 (degree Z 168), and BRCA1downregulated differentially expressed genes.
Gene symbol p
A1, COL18A1, COL8A2, COL15A1, LAMA2, LAMC2 < 0.01
3G, SEMA3C, SEMA4D, COL1A1, COL8A2, COL15A1 < 0.01
A2, COL18A1, S100A11, COL18A1, FOXC1, SMAD1 < 0.01
2, LAMA3, COL7A1, COL17A1, S100A7, SPRR1A < 0.01
A1, COL18A1, COL4A5, LAMC2, SEMA3C, SEMA3F < 0.01
A1, COL8A2, COL15A1, S100A12, SEMA3C, SEMA3G < 0.01
A1, COL6A2, COL15A1, COL18A1, SEMA3C, SEMA4D < 0.01
A1, COL8A2, COL15A1, COL18A1, LAMA2, LAMC2 < 0.01
A1, COL4A5, COL8A2, COL15A1, SEMA3F, LAMC2 < 0.01
7A1, SEMA4D, SLC1A4, SLCO2A1, SLC18A2, SLC22A1 3.24E-13
A1, COL8A2, COL15A1, COL18A1, LAMA2, LAMC3 2.46E-12
2, S100A7, S100A8, S100A10, S100A12, S100A14 4.29E-10
, KLK12, PRSS2, PRSS3, PRSS8, PRSS53 1.49E-09
2A, TUBB6, TUBBP5, KRT9, KRT19, KRT31 1.82E-09
, KLK13, PRSS2, PRSS3, PRSS8, PRSS53 2.39E-09
r functions.
Table 4 The top 10 enriched Kyoto Encyclopedia of Genes and Genomes pathways for the downregulated differentially
expressed genes.
ID Name Count Gene symbol p
4360 Axon guidance 25 EPHA1, GSK3B, SEMA3C, SEMA3F, SEMA3G, SEMA4D 2.98E-07
4512 ECM-receptor interaction 17 COL1A1, COL4A5, COL6A1, LAMA2, LAMC2, LAMC3 1.59E-05
5200 Pathways in cancer 40 GSK3B, LAMA2, LAMA3, LAMB3, LAMC3, SLC2A1 2.60E-05
5146 Amoebiasis 18 COL1A1, COL4A5, LAMA2, LAMA3, LAMC2, LAMC3 8.96E-05
4510 Focal adhesion 27 COL1A1, COL4A5, COL6A1, COL6A2, LAMA2, LAMC3 0.001
590 Arachidonic acid metabolism 12 ALOX12, ALOX12B, ALOX15, ALOX15B, GPX2, GPX3 0.002
4640 Hematopoietic cell lineage 15 IL11RA, IL1R1, IL7R, IL4R, IL1R2, CD4, CD9 0.003
5150 Staphylococcus aureus infection 11 HLA-DPA1, HLA-DPB1, HLA-DQB1, CFB, CFH, CFD 0.006
480 Glutathione metabolism 10 GSTM3, GSTA3, GSTZ1, GSTA4, GSTP1, GSTT1 0.010
5219 Bladder cancer 9 MMP1,MMP2, EGFR, FGFR3, CCND1, CDH1, ERBB2, HRAS, TYMP 0.010
ECM Z extracellular matrix.
Identification of MM related genes 557(degree Z 159). All of them were upregulated DEGs.
Furthermore, a total of 50 modules were separated, and
the module with the highest MCODE score of 48.875 was
selected for further analysis (Figure 2). In this module, a
total of 104 upregulated DEGs were involved, such as CDK1
(module degree Z 103), MAD2L1 (module degree Z 103),
RFC4 (module degree Z 102), BRCA1 (module
degreeZ 99), and PCNA (module degreeZ 97). The BRCA1
in the module was interacted with CDK1, MAD2L1, PCNA,
and RFC4 (Figure 2).
The heat map showed that most of the upregulated DEGs
such as PCNA, RFC4, BRCA1, CDK1, and MAD2L1 were
clustered in the cell cycle, negative regulation of cell cycle
process, regulation of cell cycle phase transition, as well as
cell division (Figure 3).Discussion
In our study, a total of 2012 DEGs between PM and
aggressive MMs were identified, including 1004 upregulated
and 1008 downregulated DEGs. From the PPI network we
found the top five DEGs with higher node degrees were
PCNA, CDK1, MAD2L1, RFC4, and BRCA1, and they were
involved in the module with the highest MCODE score.
Through functional and pathway enrichment analysis,
CDK1 and PCNA were enriched in the mitotic cell cycle,
membrane-enclosed lumen, small molecule binding, and
cell cycle. As previously reported, cyclin-dependent ki-
nases (CDKs), such as CDK1, regulated the progression of
cell cycle and DNA replication [18]. Additionally, prolif-
erating cell nuclear antigen (PCNA) is essential for DNATable 5 Identification of transcription factors, tumor-associate
downregulated differentially expressed genes.
DEGs TF
Upregulated BRCA1, HIF1A, TAF4, HMGA2,
TAF5, TAF7
HMGA2,
MYBL1, P
Downregulated TP63, KLF4, KLF5, KLF13,
FOXC1, FOXO4
CD24, LA
FGFR2, T
DEGs Z differentially expressed genes; TAG Z tumor-associated genreplication and is involved in DNA repair [19]. In verte-
brate cells, PCNA is crucially regulated by p21, an inhib-
itor of CDKs [20], and binding of p21 to PCNA inhibits DNA
replication [19]. The expression of PCNA is correlated
with the presence of malignancy and prognosis in
numerous melanoma patients [21]. Moreover, the
increased mRNA levels of melanoma differentiation asso-
ciated MDA6 which encodes p21, displaying a loss of
metastatic potential in MM cells. Taken together, these
studies indicated that p21 functions as a negative regu-
lator of melanoma growth, progression, and metastasis
through regulating the CDKs and PCNA. Therefore, it could
be speculated that CDK1 and PCNA participate in MM by
affecting the cell cycle.
Moreover, RFC3, RFC4, and PCNA were enriched in the
pathways of DNA replication and mismatch repair as well as
the function enrichment of mitotic cell cycle and molecular
binding. RFC1, RFC3, and RFC4 have the clamp loader ac-
tivities when PCNA acts as a clamp to repair or replicate
DNA [19]. A conserved motif of PIP box, PCNA-interacting
protein that acts as PCNA partner, was found in RFCs
[19]. When repair or replicate DNA, replication factor C
(RFC ) binds to the primer template junction and catalyzes
the loading of the ring-shaped replication factor PCNA, like
a screw cap with a bottle that encircles DNA [19]. Moreover,
the overexpression of RFC4 was highly significant in the MM
within 4 years [22]. This suggested that RFC4 and PCNA
might have crucial effects on cell cycle, mismatch repair,
and DNA replication of MM cells, thus contributes to the
development of MM.
In addition, BRCA1 and MAD2L1 were involved in mitotic
cell cycle and nuclear lumen, and BRCA1 was identified as ad genes, and tumor suppressor genes for the upregulated and
TAG TSG
CCNA2, CCNE1, PIK3CA,
IK3CA
BRCA1, SMAD4, MSH2, CDC73,
CDKN2C, TIMP3
MC2, CCND1, CCND2,
AF15
TP63, CDKN1C, KLF5, COL18A1,
CDH1, KLF10
e; TF Z transcription factor; TSG Z tumor suppressor gene.
Figure 1. Proteineprotein interaction network of the differentially expressed genes (DEGs). The red nodes indicate the upregu-
lated DEGs. The green nodes indicate the downregulated DEGs. Themolecular interactions between the DEGs are indicated by edges.
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Figure 2. The module obtained from proteineprotein interaction network with the highest score. The Molecular Complex
Detection score is 48.875. A total of 104 differentially expressed genes are included in the module, and all of them are the
upregulated differentially expressed genes, represented by the red nodes.
Identification of MM related genes 559TF and TSG. It has been reported that BRCA1 is ubiquitously
expressed and involved in cell proliferation, DNA damage
response, apoptosis, and regulation of cell cycle progres-
sion, and is required for centrosome and mitotic spindle
functions [23]. BRCA1 participated in the recruitment or
maintenance of MAD2L1 to kinetochores, and further
investigation found that BRCA1 positively regulated
MAD2L1 expression by interacting with its promoter [24]. As
previously reported, the loss or knockdown of BRCA1
induced the activation of AKT, thus inducing the protein
kinase B/mechanistic target of rapamycin signaling
pathway [25], whose constitutive expression had been
observed in most of melanomas and inhibition of AKT in the
onset and further development of melanoma altered the
progression of MM [26,27]. This suggested that BRCA1 and
MAD2L1 might have a crucial role in the progression of MMs
by participating in the cell cycle pathway, and activation of
the BRCA1 might be a potential therapeutic target to
inhibit and alter the invasion and metastasis of MM.
However, the downregulated DEGs including laminin
family members such as LAMC2 and LAMC3 and collagen
family members such as COL1A1 and COL4A5 weresignificantly involved in cell adhesion, ECM, ECM-receptor
interaction, and focal adhesion, and COL18A1 and LAMC2
was identified as the TSG and TAG, respectively. In addition
to the hyperactivity of cell proliferation, metastasis is
facilitated by cellecell interactions between tumor cells
and the endothelium in distant tissues. Laminin and
collagen are ECM proteins that play important roles in
maintaining the integrity of various tissues and mediating
the adhesion, migration, and organization of cells into tis-
sues. TGF-b induced protein (TGF-bI) is a TGF-b inducible,
secreted ECM protein impairs the adhesive contacts of
melanoma cells with the ECM molecules, including type I
collagen, type IV collagen, and laminin, and, therefore,
promotes melanoma cell migration and metastatic pro-
gression [28,29]. However, the knockdown of SPARC with
siRNA increased the expression of COL1A1 and COL3A1 and
resulted in a significant decrease of proliferation in uveal
melanoma cell lines. Furthermore, LAMC2 and LAMA4 were
particularly overexpressed in angiotropic melanoma areas
versus nonangiotropic areas, suggesting the increased
LAMC2 and LAMA4 enhanced the focal adhesive ability of
melanoma cells [30]. This phenomenon demonstrated that
Figure 3. The heat map of function enrichment of the 104
differentially expressed genes in the module. The horizontal
560 T. Qiu et al.the laminin and collagen family members such as LAMC2,
COL1A1, and COL18A1 might affect the cell and focal
adhesion of the MM cells, and thus might play an important
part in the progression of MM.
In conclusion, 2012 DEGs between the PM and MM
groups were identified. The upregulated DEGs such as
CDK1, PCNA, RFC4, BRCA1, and MAD2L1 were significantly
involved in the cell cycle and proliferation, and down-
regulated DEGs, such as LAMA2, LAMC2, COL1A1, and
COL4A5 were involved in cell adhesion and ECM-receptor
interaction, respectively. Furthermore, the upregulated
DEGs had higher scores in the PPI network, such as CDK1,
PCNA, RFC4, and BRCA1. These DEGs might be involved in
the process of MM. However, further experimental verifi-
cation is still needed to confirm the potential effects of
the DEGs in MM.References
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